U.S. Labor Board Drops SpaceX Wrongful-Termination Case, Citing Lack of Jurisdiction

The National Labor Relations Board has dismissed its wrongful-termination complaint against SpaceX (filed January 2024 regarding eight engineers fired after a June 2022 open letter), citing lack of jurisdiction after the National Mediation Board ruled that space transportation falls under NMB authority. The NMB's determination — influenced by a change in administration — effectively removes a two-year legal overhang for CEO Elon Musk and strengthens SpaceX's legal position, while fired employees face increased difficulty pursuing their case.

Analysis

Market structure: The NMB ruling materially lowers legal risk for SpaceX (private), improving its competitive posture for commercial and DoD launch awards; expect downward pressure on pricing for small/medium launch services as SpaceX leverages scale, pressuring publicly traded peers (RKLB, small-cap launch suppliers) over 3–24 months. Large defense primes (LMT, RTX, BA) gain clarity around subcontracting and supplier volume but face strategic share loss in pure-play launch revenue; overall demand for launch capacity should rise while average selling prices for commoditized rideshare/LEO access fall by an incremental ~5–20% over several years.

Risk assessment: Tail risks include a judicial reversal of NMB jurisdiction, Congressional/DoD procurement limits on SpaceX (low-probability, high-impact) and talent/PR risk leading to operational disruption; probability <25% in 12 months but impact high. Immediate (days/weeks): sentiment moves in aerospace small-caps; short-term (3–6 months): contract award timing effects; long-term (1–5 years): market-share reallocation and margin compression for pure-play launchers.

Trade implications: Favor large-cap aerospace/defense exposure via ITA or selective longs in LMT/RTX for 6–12 months (structural defense budgets + broader capex tailwind) while shorting/hedging small-cap launchers (RKLB) via equity or put spreads sized to 1–2% portfolio. Use options to express view: buy 3–6 month put spreads on RKLB (10–20% OTM) and 6–12 month call spreads on LMT/RTX to limit capital at risk and time exposure to procurement cycles (~90–180 day windows).

Contrarian angles: Consensus assumes regulatory permanence — underestimate legal appeal risk and employee attrition/reputational costs that can induce contract delays; market may be underpricing the chance of DoD non-reliance on commercial launch capacity. If SpaceX’s pricing squeezes competitors faster than expected, small-caps could face >30% revenue downside in 12–36 months, so size shorts conservatively and hedge with defense long exposure.

Key Decisions for Investors

• Establish a 2.5% portfolio long position split equally (1.25% each) in Lockheed Martin (LMT) and Raytheon Technologies (RTX), horizon 6–12 months; set stop-loss at -8% and trim to take profits at +20% or upon confirmed large DoD award losses to SpaceX.
• Initiate a 1.5% short exposure to Rocket Lab (RKLB) via equity or equivalent CFD, paired with a protective call at +30% to cap loss; alternative: buy a 0.5% portfolio-sized 3–6 month put spread 10–20% OTM if liquidity/option skew allows. Hold up to 12 months unless RKLB shows >15% revenue growth guidance revisions.
• Rotate 50% of existing small-cap aerospace ETF exposure (e.g., XAR) into large-cap aerospace/defense ETF ITA over the next 30 days to reduce pure-play launch risk; reallocate proceeds to the LMT/RTX positions outlined above.
• Deploy a tactical 0.5% portfolio position in 6–12 month call spreads on LMT or RTX (bull call spreads) to gain leveraged upside into expected procurement cycles; unwind if DoD/USAF contract award announcements (next 90–180 days) show material shift away from commercial providers.